Janus kinase (JAK) inhibitors, including ruxolitinib cream and abrocitinib, demonstrate strong efficacy in atopic dermatitis ...

Several characteristics, including BMI and Charlson Comorbidity Index, were associated with super response to biologics in patients with psoriasis.

Johnson & Johnson today announced it has completed its acquisition of Intra-Cellular Therapies, Inc. Intra-Cellular Therapies is now part of Johnson & Johnson and will operate as a business unit ...

Here are some reasons you may be getting flare-ups of atopic dermatitis (eczema), according to dermatologists, plus solutions to avoid these triggers.

You have atopic dermatitis, better known as eczema. According to the National Eczema Association, more than 31 million people in the United States alone experience this genetic skin condition.